Shah Nikita Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$2.06M

Insider Activity of Shah Nikita

According to the SEC Form 4 filings, Shah Nikita, being in a position of

  1. Executive Vice President at Amneal Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 278259 shares for $4.14M,
    over all time since 2018-08-21, has bought 0 shares, and sold 758255 shares for $8.85M.

Biography of Shah Nikita

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$4,135,2402100

Comparison of Insiders on Amount of Buys and Sells

2026-08-12SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
146,403
0.0455%
$17.51$2.56M+9.23%
2025-11-12SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
131,856
0.044%
$11.92$1.57M+17.9%
2025-08-25SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
6,340
0.002%
$9.50$60,230+38.15%
2025-08-22SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
114,492
0.0367%
$9.66$1.11M+33.47%
2025-08-14SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
71,694
0.0226%
$9.29$666,037+35.36%
2025-08-12SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
50,000
0.0163%
$9.04$452,000+40.91%
2025-05-16SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
49,140
0.0105%
$7.58$372,481+52.76%
2024-08-14SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
100,000
0.0335%
$7.75$775,000+5.57%
2021-12-15SaleAmneal Pharmaceuticals, Inc.
AMRX
Executive Vice President
2,000
0.0013%
$3.95$7,900-19.2%
2021-03-15SaleAmneal Pharmaceuticals, Inc.
AMRX
SVP, Chief HR Officer
36,330
0.0097%
$2.75$99,908-26.36%
2018-08-21SaleAmneal Pharmaceuticals, Inc.
AMRX
SVP, Chief HR Officer
50,000
0.0388%
$23.46$1.17M-43.31%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.